Liraglutide (Saxenda), a daily GLP-1 receptor agonist injection, represents another option, though the increased injection frequency may not appeal to all patients
With effective pharmacotherapy likely available in the near future, referral pathways will need to be altered to identify At Risk MASH (MASH and significant fibrosis, F2/F3 stage), the patient group targeted in current clinical trials
However, experts caution that it should only be used under medical supervision
Rarely, some patients experience reduced medication tolerability that leads them to skip doses or stop therapy prematurelythis allows hunger to return
If you have type 1 diabetes, you need to take insulin to manage your blood sugar and prevent it from getting too high